FDA Inspection
VA Health Care System (113)VA Health Care System (113) – FDA Inspection, Mar 12, 2012
Record Details
This FDA Inspection record concerns VA Health Care System (113), with an inspection on March 12, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- VA Health Care System (113)
- Inspection Date
- March 12, 2012
- Product Type
- Biologics
View Company Profile
ID · eb0fdd63-d64c-4488-a35b-358087c4641f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 769996
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.20(b)Qualifications of responsible personnel
Full citation text and observation details available on the Dashboard.
Other FDA inspections of VA Health Care System (113)
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2025 | VAI | Minneapolis District Office | Blood and Blood Products |
| May 27, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 28, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 3, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 12, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for VA Health Care System (113)
- FDA Inspection 1272899 - 2025-06-13
- FDA Inspection 1171558 - 2022-05-27
- FDA Inspection 1054299 - 2018-03-28
- FDA Inspection 983029 - 2016-05-03
- FDA Inspection 882868 - 2014-06-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.